“What Biopharmas Need To Know About Genetic Data Privacy”

  • October 1, 2021

Keith F. Noe

Article published in Life Science Leader

Although accessing genomic data provides biopharmaceutical companies valuable insight to develop therapeutically effective drugs, the access to such data also raises the possibility of exposing consumers’ personal and private information, requiring that companies have an exceptional level of responsibility to secure the information and protect the consumers’ privacy.

The full article was published in Life Science Leader.


How can we help you?